miRNome profiling of LSC-enriched CD34(+)CD38(−)CD26(+) fraction in Ph(+) CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool

Chronic myeloid leukemia (CML) is a myeloid stem cell neoplasm characterized by an expansion of myeloid progenitor cells and the presence of BCR-ABL1 oncoprotein. Since the introduction of specific BCR-ABL1 tyrosine kinase inhibitors (TKI), overall survival has improved significantly. However, under...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, María Sol, Sánchez, María Belén, Bonecker, Simone, Furtado, Carolina, Koile, Daniel, Yankilevich, Patricio, Cranco, Santiago, Custidiano, María del Rosario, Freitas, Josefina, Moiraghi, Beatriz, Pérez, Mariel Ana, Pavlovsky, Carolina, Varela, Ana Inés, Ventriglia, Verónica, Sánchez Ávalos, Julio César, Larripa, Irene, Zalcberg, Ilana, Mordoh, José, Valent, Peter, Bianchini, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869017/
https://www.ncbi.nlm.nih.gov/pubmed/33569005
http://dx.doi.org/10.3389/fphar.2020.612573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869017/
https://www.ncbi.nlm.nih.gov/pubmed/33569005
http://dx.doi.org/10.3389/fphar.2020.612573

Ejemplares similares